Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a biopharmaceutical company focused on developing innovative treatments for serious and complex diseases. As a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation, we draw upon over 300 years of pharmaceutical heritage while advancing modern therapies in neurology, immunology and rare diseases. Our team is committed to translating scientific discovery into meaningful therapi...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a biopharmaceutical company focused on developing innovative treatments for serious and complex diseases. As a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation, we draw upon over 300 years of pharmaceutical heritage while advancing modern therapies in neurology, immunology and rare diseases. Our team is committed to translating scientific discovery into meaningful therapies that address unmet medical needs. We maintain rigorous research standards and collaborate with healthcare partners to deliver transformative solutions for patients who need them most.

List your booth number for exhibitions, ask us